(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.05%) $0.927
(0.25%) $10.87
(0.06%) $0.793
(-0.29%) $92.31
Live Chart Being Loaded With Signals
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally...
Stats | |
---|---|
Today's Volume | 39 379.00 |
Average Volume | 264 588 |
Market Cap | 18.04M |
EPS | £-0.124 ( 2011-06-30 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -1.540 |
ATR14 | £0 (0.00%) |
Ondine Biomedical Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ondine Biomedical Inc. Financials
Annual | 2022 |
Revenue: | £638 000 |
Gross Profit: | £287 000 (44.98 %) |
EPS: | £-0.110 |
Q2 | 2023 |
Revenue: | £257 508 |
Gross Profit: | £-25 872.00 (-10.05 %) |
EPS: | £-0.0244 |
Q4 | 2022 |
Revenue: | £240 478 |
Gross Profit: | £-60 120.00 (-25.00 %) |
EPS: | £-0.0355 |
Q2 | 2017 |
Revenue: | £640 043 |
Gross Profit: | £422 967 (66.08 %) |
EPS: | £-0.120 |
Financial Reports:
No articles found.
Ondine Biomedical Inc.
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators